If you search on Google Scholar using terms like "GLP-1 supplements," "GIP supplements," and "incretin mimetics," you will find many scientific papers about these topics
By the time a patient raises the subject with their physician, they may have been exposed to this information environment for months, and their expectations have been calibrated accordingly
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial
Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study
Standard-dose protocols may produce stronger appetite suppression, but they can also create a higher likelihood of noticeable side effects during escalation
There are currently no FDA-approved drug therapies for MASH, and the disease is characterized by excess fat accumulation and inflammation in the liver, which leads to liver scarring or fibrosis